Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Cresci

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Expert Opinion on Pharmacotherapy|December 1, 2005
The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogeneticsSharon Cresci
Pharmacogenomics|November 24, 2007
Pharmacogenetics of the PPAR genes and cardiovascular diseaseSharon Cresci
PPAR Research|April 11, 2008
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular DiseaseSharon Cresci
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
From SNPs to functional studies in cardiovascular pharmacogenomicsSharon Cresci
Journal of the American College of Cardiology|December 24, 2011
ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular diseaseSharon Cresci
Pharmacogenomics|July 4, 2008
The mechanistic imperative for pharmacogenomicsGerald W Dorn, Sharon Cresci
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 9, 2007
Image-guided cardiovascular functional genomics: finding the needle in the haystackSharon Cresci, Robert J Gropler
Heart Failure Reviews|November 11, 2008
PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failureNeville F Mistry, Sharon Cresci
Personalized Medicine|May 15, 2018
CYP450 pharmacogenomics: a cardiology perspectiveJeremiah P Depta, Sharon Cresci
Pharmacogenomics|February 12, 2009
Genome-wide association studies of coronary artery disease and heart failure: where are we going?Gerald W Dorn, Sharon Cresci
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Expert Opinion on Pharmacotherapy|December 1, 2005
The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogeneticsSharon Cresci
Pharmacogenomics|November 24, 2007
Pharmacogenetics of the PPAR genes and cardiovascular diseaseSharon Cresci
PPAR Research|April 11, 2008
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular DiseaseSharon Cresci
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
From SNPs to functional studies in cardiovascular pharmacogenomicsSharon Cresci
Journal of the American College of Cardiology|December 24, 2011
ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular diseaseSharon Cresci
Pharmacogenomics|July 4, 2008
The mechanistic imperative for pharmacogenomicsGerald W Dorn, Sharon Cresci
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 9, 2007
Image-guided cardiovascular functional genomics: finding the needle in the haystackSharon Cresci, Robert J Gropler
Heart Failure Reviews|November 11, 2008
PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failureNeville F Mistry, Sharon Cresci
Personalized Medicine|May 15, 2018
CYP450 pharmacogenomics: a cardiology perspectiveJeremiah P Depta, Sharon Cresci
Pharmacogenomics|February 12, 2009
Genome-wide association studies of coronary artery disease and heart failure: where are we going?Gerald W Dorn, Sharon Cresci
Pageof 8